Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas: A correlative study of 942 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 4, 1996, Pages 219-227

  MacGrogan, G ^a   Soubeyran, I ^a   De Mascarel, I ^a   Wafflart, J ^a   Bonichon, F ^a   Durand, M ^a   Avril, A ^a   Mauriac, L ^a   Trojani, M ^a   Coindre, J M ^a,b  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Breast carcinoma; Breast neoplasm; Concordance prognostic significance; Dextrancoated charcoal method; Immunohistochemical analysis; Progesterone receptor

Indexed keywords

PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030443656     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Horwitz KB, McGuire WL, Pearson OH, Segaloff A. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 1975;189:726-7.
2. Clark GM, McGuire WL. Progesterone receptors and human breast cancer. Breast Cancer Res Treat 1983;3:157-63.
3. Pichon MF, Pallud C, Brunet M, Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 1980;40:3357-60.
4. Bertuzzi A, Vezzoni P, Ronchi E. Prognostic importance of progesterone receptors alone or in combination with estrogen receptors in node negative breast carcinoma. Proc AACR ASCO 1981; 22:447.
5. Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS. Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 1983;309:1343-7.
6. Logeat F, Vu Hai MT, Fournier A, Legrain P, Buttin G, Milgrom E. Monoclonal antibodies to rabbit progesterone receptor: cross-reaction with other mammalian progesterone receptors. Proc Natl Acad Sci USA 1983;80:6455-9.
7. Helin HJ, Helle MJ, Helin ML, Isola JJ. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Am J Clin Pathol 1988;89:137-42.
8. Pertschuk LP, Feldman JG, Eisenberg KB, et al. Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody: relation to biochemical assay, disease-free survival, and clinical endocrine response. Cancer 1988;62:342-9.
9. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990;50:7057-61.
10. 3 receptor in breast cancer and relationship to prognosis. Cancer Res 1991;51:239-44.
11. El-Badawy N, Cohen C, Derose PB, Check IJ, Sgoutas D. Immunohistochemical progesterone receptor assay: measurement by image analysis. Am J Clin Pathol 1991;96:704-10.
12. Aziz DC. Quantitation of estrogen and progesterone reeptors by immunocytochemical and image analyses. Am J Clin Pathol 1992; 98:105-11.
13. Gasparini G, Pozza F, Dittadi R, Meli S, Cazzavillan S, Bevilacqua P. Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer. J Cancer Res Clin Oncol 1992;118:557-63.
14. Tesch M, Shawwa A, Henderson R. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol 1993;99:8-12.
15. Beck T, Weikel W, Brumm C, Wilkens C, Pollow K, Knapstein PG. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Gynecol Oncol 1994;53:220-7.
16. Jacquemier J, Boudaoura T, Martin PM, Torrente M, Hassoun J. Carcinomes mammaires humains inclus en paraffine, fixés dans le liquide de Bouin. Analyse immunohistochimique des récepteurs d'estrogène et de progestérone. Ann Pathol 1991;4:224-30.
17. Masood S, Dee S, Goldstein JD. Immunocytochemical analysis of progesterone receptors in breast cancer. Am J Clin Pathol 1991; 96:59-63.
18. Ozzello L, deRosa C, Habif DV, Green GL. An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas. Cancer 1991;67:455-62.
19. Goldberg DE, Stuart J, Koerner FC. Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating. Mod Pathol 1994;7:401-6.
20. de Mascarel I, Soubeyran I, MacGrogan G, et al. Immunohistochemical analysis of estrogen receptors in 938 breast carcinomas: concordance with biochemical assay and prognostic significance. Appl Immunohistochem 1995;3:222-31.
21. Shi S, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
22. Battifora H, Mehta P. Comparison of antibodies to progesterone receptor. Appl Immunohistochem 1993;1:83-41.
23. Leong ASY, Milios J. Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave-antigen retrieval. Appl Immunohistochem 1993;1:282-8.
24. Perrot-Applanat M, Groyer-Picard MT, Vu Hai MT, Pallud C, Spyratos F. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers. Am J Pathol 1989;135:457-68.
25. Giri DD, Goepel JR, Rogers K, Underwood JC. Immunohistological demonstration of progesterone receptors in breast carcinomas correlation with radioligand binding assays and estrogen receptor immunohistology. J Clin Pathol 1988;41:444-7.
26. Helin H, Isola J, Helle M, Koivula T. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma. Br J Cancer 1990;62:109-12.
27. Stierer M, Rosen H, Weber R, Hanak H, Auerbach L, Spona J, Tüchler H. A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer. Breast Cancer Res Treat 1995;36:11-21.
28. Berardo M, Clark GM, de Moor C, Osborne CK, Weigand RA, Allred DC. Prognostic and predictive properties of immunohistochemical progesterone receptors in breast cancer. Proc ASCO 1995;14:110.
29. Pertschuk LP, Kim DS, Nayer K, et al. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies: histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 1990;66:1663-70.
30. Soomro S, Shousha S, Sinnett HD. Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections. Histopathology 1992;21: 543-7.
31. Hurlimann J, Gebhard S, Gomez F. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology 1993;23:239-48.
32. Kaldjian EP, Jin L, Davenport RD, Lloyd RV. Immunohistochemical analysis of hormone receptors, tumor vascularity, and proliferative activity in paraffin-embedded sections of breast carcinoma tissues. Appl Immunohistochem 1993;1:31-8.
33. Kommoss F, Pfisterer J, Idris T, et al. Steroid receptors in carcinoma of the breast: results of immunocytochemical and biochemical determination and their effects on short-term prognosis. Analyt Quant Cytol Histol 1994;16:203-10.
34. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Bayer R, Keiding N, on behalf of the Danish Breast Cancer Cooperative Group. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res 1987;47:6126-33.
35. Clark GM, Osborne CL, McGuire WL. Correlations between estrogen receptor, progesterone receptor and patient characteristics in human breast cancer. J Clin Oncol 1984;9:1102-9.
36. Spyratos F, Hacene K, Tubiana-Hulin M, Pallud C, Brunet M. Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer: a sequential multivariate analysis of 1262 patients. Eur J Cancer Clin Oncol 1989;25:1233-40.
37. Chevallier B, Heintzmann F, Mosseri V, et al. Prognostic value of estrogen and progesterone receptors in operable breast cancer: results of a univariate and multivariate analysis. Cancer 1988;62: 2517-24.
38. Saez S, Cheix F, Asselain B. Prognostic value of estrogen and progesterone receptors in primary breast cancer. Breast Cancer Res Treat 1983;3:345-53.
39. Raemaekers JMM, Beex LVAM, Pieters GFFM, Smals AGH, Benraad TJ, Kloppenborg PWC, and the Breast Cancer Study Group. Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy. Breast Cancer Res Treat 1987;9:191-9.
40. Mathiesen O, Bonderup O, Carl J, Panduro J, Pedersen KO. The prognostic value of estrogen and progesterone receptors in female breast cancer: a single center study. Acta Oncol 1991;30:691-5.